Metraipolis › archive › dc_ad2001a0293a

Effects of TGMXD-208, a Novel PI3K Inhibitor, on Adjuvant-induced Arthritis Rats by Suppressing PI3K/AKT Signaling Pathway — Europe PMC PMID:40415316

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/40415316
DOI
10.2174/0118715303373717250509063328
License (as archived)
solo-consultazione
Archived
2026-11-07T04:44:08.859Z
SHA-256 of the archived text
f61349887daf8614f1b4f151eb98964dff10e48e065a71c645a2d21bb1a60269
Stable URL of this page
https://metraipolis.com/documento/dc_ad2001a0293a

How to cite

Effects of TGMXD-208, a Novel PI3K Inhibitor, on Adjuvant-induced Arthritis Rats by Suppressing PI3K/AKT Signaling Pathway — Europe PMC PMID:40415316 — Europe PMC (en), https://europepmc.org/article/MED/40415316 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_ad2001a0293a (Metraipolis archive dc_ad2001a0293a, sha256 f61349887daf8614f1b4f151eb98964dff10e48e065a71c645a2d21bb1a60269)
BibTeX
@misc{dcad2001a0293a,
  title = {Effects of TGMXD-208, a Novel PI3K Inhibitor, on Adjuvant-induced Arthritis Rats by Suppressing PI3K/AKT Signaling Pathway — Europe PMC PMID:40415316},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/40415316},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_ad2001a0293a; sha256 f61349887daf8614f1b4f151eb98964dff10e48e065a71c645a2d21bb1a60269},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/40415316. Agents can read the archived copy with the MCP tool read_document.